Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Substance Abuse Treatment Industry Worth Over $21 Billion by 2032 - Integrated Care Models, Telehealth Expansion, Value-Based Payment Structures, and Digital Tools Present Lucrative Opportunities

globenewswire.com
ACAD Mentioned as a key player in the substance abuse treatment market, indicating its involvement in a growing industry. The article does not provide specific performance data or outlook for Acadia. UHS Listed as a key stakeholder in the substance abuse treatment market. The article highlights the industry's growth and trends, but does not offer specific sentiment or performance details for UHS.

Substance Abuse Treatment Industry Worth Over $21 Billion by 2032 - Integrated Care Models, Telehealth Expansion, Value-Based Payment Structures, and Digital Tools Present Lucrative Opportunities Dublin, March 16, 2026 (GLOBE NEWSWIRE) -- The "Substance Abuse Treatment Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

The Substance Abuse Treatment Market has experienced significant growth from USD 13.04 billion in 2025 to USD 13.93 billion in 2026, with a projected CAGR of 7.26%, expecting to reach USD 21.32 billion by 2032. This research report provides an actionable overview of the evolving substance abuse treatment landscape, integrating insights on clinical, technological, and policy advancements. Designed for executives, the report highlights critical intersections between operational priorities and patient needs, aiding in strategic investment and governance alignment against a backdrop of regulatory evolution.

Transformative Shifts in Care Delivery

Substance abuse treatment delivery is evolving through clinical innovation, extensive digital health adoption, and payment reform. Integrated care models are embedded into primary care, facilitating early identification and streamlined referrals. Telehealth is now a core treatment modality, enhancing access but introducing considerations around care continuity and digital equity.

Value-based payment initiatives encourage the development of treatment pathways emphasizing sustained recovery. Advances in medication-assisted treatment and harm reduction strategies are impacting clinical workflows. To capitalize on these trends, organizations must focus on interoperability and workforce development, ultimately leading to enhanced patient retention and recovery outcomes.

Regional Dynamics and Strategic Implications

Regional factors significantly impact service delivery and necessitate tailored strategies. In the Americas, the integration of behavioral health within primary care has driven outpatient and telehealth expansion. Europe, Middle East & Africa present a complex regulatory landscape requiring adaptable program models. Asia-Pacific's digital health growth and urban-rural provider disparities demand focused workforce training and community engagement strategies.

Understanding these regional dynamics enables stakeholders to design scalable, culturally sensitive care models, enhancing adoption and best practice diffusion.

Insights on Key Stakeholder Collaborations

Organizations across the substance abuse treatment ecosystem are aligning through integrated care, digital tools, and outcome-oriented frameworks. Clinical providers advance through telehealth-enabled continuity and community partnerships. Technology companies offer solutions for remote monitoring and digital therapeutics, while pharmaceutical companies ensure medication-assisted therapy supply chains.

Payers move toward performance metrics and outcome-based models that support sustained recovery. These strategic alliances are crucial for bundled payment models and care registries, establishing competitive advantage through higher-value care and compliance management.

Key Takeaways from This Report

Key Attributes

Key Topics Covered

1. Preface

2. Research Methodology

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. Market Size & Growth Trends

3.4. Market Share Analysis, 2025

3.5. FPNV Positioning Matrix, 2025

3.6. New Revenue Opportunities

3.7. Next-Generation Business Models

3.8. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Porter's Five Forces Analysis

4.4. PESTLE Analysis

4.5. Market Outlook

4.5.1. Near-Term Market Outlook (0-2 Years)

4.5.2. Medium-Term Market Outlook (3-5 Years)

4.5.3. Long-Term Market Outlook (5-10 Years)

4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Substance Abuse Treatment Market, by Treatment Mode

8.1. Day Treatment

8.2. Detoxification

8.2.1. Medical Detox

8.2.2. Non Medical Detox

8.3. Inpatient

8.3.1. Hospital Based Inpatient

8.3.2. Residential Inpatient

8.4. Outpatient

8.4.1. Intensive Outpatient Program

8.4.2. Standard Outpatient Program

8.5. Telehealth

8.5.1. Asynchronous Telehealth

8.5.2. Synchronous Telehealth

9. Substance Abuse Treatment Market, by Substance Type

9.1. Alcohol

9.2. Cannabis

9.3. Opioids

9.4. Stimulants

10. Substance Abuse Treatment Market, by Service Provider

10.1. Clinic

10.2. Homecare

10.3. Hospital Based Centre

10.4. Standalone Rehab Center

11. Substance Abuse Treatment Market, by Payment Mode

11.1. Private Insurance

11.2. Public Funding

11.3. Self Pay

12. Substance Abuse Treatment Market, by End User

12.1. Adolescents

12.2. Adults

12.3. Geriatric

13. Substance Abuse Treatment Market, by Region

13.1. Americas

13.1.1. North America

13.1.2. Latin America

13.2. Europe, Middle East & Africa

13.2.1. Europe

13.2.2. Middle East

13.2.3. Africa

13.3. Asia-Pacific

14. Substance Abuse Treatment Market, by Group

14.1. ASEAN

14.2. GCC

14.3. European Union

14.4. BRICS

14.5. G7

14.6. NATO

15. Substance Abuse Treatment Market, by Country

15.1. United States

15.2. Canada

15.3. Mexico

15.4. Brazil

15.5. United Kingdom

15.6. Germany

15.7. France

15.8. Russia

15.9. Italy

15.10. Spain

15.11. China

15.12. India

15.13. Japan

15.14. Australia

15.15. South Korea

16. United States Substance Abuse Treatment Market

17. China Substance Abuse Treatment Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025

18.1.1. Concentration Ratio (CR)

18.1.2. Herfindahl Hirschman Index (HHI)

18.2. Recent Developments & Impact Analysis, 2025

18.3. Product Portfolio Analysis, 2025

18.4. Benchmarking Analysis, 2025

18.5. Acadia Healthcare Company, Inc.

18.6. Advanced Recovery Systems, LLC

18.7. American Addiction Centers, Inc.

18.8. Caron Treatment Centers, Inc.

18.9. CleanSlate Centers, LLC

18.10. Hazelden Betty Ford Foundation

18.11. Odyssey House, Inc.

18.12. Orexo AB

18.13. Phoenix House Foundation

18.14. Recovery Centers of America, LLC

18.15. Universal Health Services, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/w54zz6

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment